| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
phosphomannomutase 2 | 0.535 | 0.769 | 1.4E-17 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
serpin family A member 3 | 0.486 | 0.846 | 8.8E-14 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
integrin subunit alpha M | 0.443 | 0.808 | 3.3E-11 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2005 | 2005 | ||||||||
|
POTE ankyrin domain family member M | 0.541 | 0.769 | 3.2E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
actin gamma 1 | 0.477 | 0.846 | 4.8E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 1 | 2019 | 2019 | ||||||||
|
DAN domain BMP antagonist family member 5 | 0.780 | 0.154 | 2.0E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
actin gamma 2, smooth muscle | 0.505 | 0.808 | 7.1E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
vascular cell adhesion molecule 1 | 0.422 | 0.808 | 0.80 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
POTE ankyrin domain family member K, pseudogene | 0.542 | 0.769 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | |||||||||
|
solute carrier family 5 member 2 | 0.499 | 0.769 | 4.9E-14 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2020 | 2020 | ||||||||
|
actin beta like 2 | 0.539 | 0.769 | 5.8E-16 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
NFKB inhibitor like 1 | 0.653 | 0.615 | 2.6E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | ||||||||
|
four and a half LIM domains 5 | 0.530 | 0.769 | 4.8E-10 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
lipase G, endothelial type | 0.633 | 0.615 | 1.0E-10 |
|
disease | 0.010 | None | < 0.001 | 1 | 3 | 2010 | 2010 | ||||||||
|
acyl-CoA thioesterase 7 | 0.531 | 0.769 | 0.76 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2005 | 2009 | ||||||||
|
fibrinogen beta chain | 0.584 | 0.692 | 0.57 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2002 | 2005 | ||||||||
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase | 0.502 | 0.808 | 2.2E-14 |
|
disease | 0.020 | None | 0.500 | 2 | 1 | 2008 | 2018 | ||||||||
|
POU class 2 homeobox 3 | 0.626 | 0.731 | 1.0E-06 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2001 | 2011 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2011 | 2019 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 13 | 0.496 | 0.769 | 5.1E-15 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2011 | 2016 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2002 | 2007 |